rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2009-6-15
|
pubmed:abstractText |
T-cell lymphomas (TCLs) classically have a poorer response to therapy when compared with B-cell lymphomas and account for only 10-15% of all lymphoid malignancies. Hepatosplenic TCLs are a rare subset of this group that usually present with hepatosplenomegaly, B-symptoms, and only rarely with lymphadenopathy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1534-4681
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2014-7
|
pubmed:dateRevised |
2009-11-12
|
pubmed:meshHeading |
pubmed-meshheading:19408055-Aminopterin,
pubmed-meshheading:19408055-Fatal Outcome,
pubmed-meshheading:19408055-Hematologic Agents,
pubmed-meshheading:19408055-Humans,
pubmed-meshheading:19408055-Laparoscopy,
pubmed-meshheading:19408055-Liver Neoplasms,
pubmed-meshheading:19408055-Lymphoma, T-Cell,
pubmed-meshheading:19408055-Male,
pubmed-meshheading:19408055-Middle Aged,
pubmed-meshheading:19408055-Splenectomy,
pubmed-meshheading:19408055-Splenic Neoplasms,
pubmed-meshheading:19408055-Thrombocytopenia,
pubmed-meshheading:19408055-Treatment Outcome,
pubmed-meshheading:19408055-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia.
|
pubmed:affiliation |
Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. aagumbs@gmail.com
|
pubmed:publicationType |
Journal Article,
Case Reports
|